Why Does Chronic Lymphocytic Leukemia Remain a Silent Threat?
🔍What is Chronic Lymphocytic Leukemia? Chronic Lymphocytic Leukemia (CLL) is a slow-growing blood cancer characterized…
News
How to Catch Ovarian Cancer Early: Signs, Risks & 5 Proactive Steps
Ovarian cancer is often called a “silent killer” because its early symptoms are vague and…
Hemophilia A: Is a Cure Possible?
🧬 What is the Hemophilia Type A? Hemophilia A, or classic hemophilia, is a rare…
Can We Outsmart Multiple Myeloma’s Genetic Maze?
Multiple myeloma (MM) is a type of blood cancer that affects plasma cells, a crucial…
Sogroya® (Somapacitan): The First Once-Weekly Long-Acting Growth Hormone Therapy
Novo Nordisk announced that its innovative growth hormone analogue Sogroya® (somapacitan) has been approved by…
Could You Have COPD Without Knowing It?
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that affects millions worldwide, causing…
Impavido: A Lifesaving Drug In The Fight Against Leishmaniasis Faces Global Access Challenges
In a world still grappling with neglected tropical diseases, Impavido (generic name: miltefosine) remains one…
Imdelltra (Tarlatamab-Dlle): A Breakthrough In Treating Extensive-Stage Small Cell Lung Cancer
Imdelltra™ (tarlatamab-dlle) represents a significant advancement in the treatment of extensive-stage small cell lung cancer…
Comments Off On Pfizer’s Hympavzi Approved By FDA For Use In Treating Hemophilia Symptoms
HYMPAVZI is the first and only anti-tissue factor pathway inhibitor (anti-TFPI) approved in the U.S.…
Fampyra (Fampridine): Enhancing Mobility In Multiple Sclerosis Patients
Fampyra, known generically as fampridine or 4-aminopyridine, is an oral medication approved to improve walking…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights